Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid.

Miguel Ángel Amor-GarcíaCarmen Guadalupe Rodríguez-GonzálezEsther Chamorro-De-VegaAna Herranz-AlonsoMaría Sanjurjo-Sáez

Published in: The Annals of pharmacotherapy (2021)

The use of DTG-based dual therapies has increased in real life, showing a favorable effectiveness and safety profile. Treatment costs increased, except for the switch to DTG plus 3TC.

Keyphrases

end stage renal disease
antiretroviral therapy
ejection fraction
newly diagnosed
chronic kidney disease
hiv infected
human immunodeficiency virus
hepatitis c virus
prognostic factors
peritoneal dialysis
hiv aids
patient reported outcomes
hiv infected patients
combination therapy
smoking cessation